![Shalom Jacobovitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shalom Jacobovitz
Directeur/Membre du Conseil chez
CLENE INC.
Fortune : 24 613 $ au 31/05/2026
Profil
Shalom Jacobovitz currently works at CiVi Biopharma, Inc., as Chief Executive Officer & Director from 2018, CiVi Biopharma Holdings, Inc., as Chief Executive Officer & Director, Eicos Sciences, Inc., as Chief Executive Officer, Clene Nanomedicine, Inc., as Director, and Clene, Inc., as Independent Director from 2021.
Mr. Jacobovitz also formerly worked at American College of Cardiology Foundation, as Chief Executive Officer from 2013 to 2018 and Actelion Pharmaceuticals US, Inc., as President from 2003 to 2013.
Mr. Jacobovitz received his undergraduate degree in 1986 from the University of Western Ontario.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CLENE INC 0,03 % | 21/05/2026 | 3 752 ( 0,03 % ) | 24 613 $ | 31/05/2026 |
Postes actifs de Shalom Jacobovitz
| Sociétés | Poste | Début |
|---|---|---|
| CLENE INC. | Directeur/Membre du Conseil | 01/05/2021 |
CiVi Biopharma, Inc.
 CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Directeur Général | 02/02/2018 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Directeur/Membre du Conseil | - |
CiVi Biopharma Holdings, Inc.
 CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Directeur Général | - |
Anciens postes connus de Shalom Jacobovitz
| Sociétés | Poste | Fin |
|---|---|---|
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Directeur Général | 01/02/2018 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | President | 01/04/2013 |
Formation de Shalom Jacobovitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company which develops clean-surface nontherapeutic medicines | Health Technology |
CiVi Biopharma, Inc.
CiVi Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which manufactures novel therapies against cardiovascular and metabolic diseases | Health Technology |
CiVi Biopharma Holdings, Inc.
CiVi Biopharma Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage research and development biotechnology company | Commercial Services |
Clene, Inc.
 Clene, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
